65-4107. Substances included in schedule II. (a) The controlled substances listed in this section are included in schedule II and the number set forth opposite each drug or substance is the DEA controlled substances code which has been assigned to it.
(b) Any of the following substances, except those narcotic drugs listed in other schedules, whether produced directly or indirectly by extraction from substances of vegetable origin or independently by means of chemical synthesis or by combination of extraction and chemical synthesis:
(1) Opium and opiate and any salt, compound, derivative or preparation of opium or opiate, excluding apomorphine, dextrorphan, nalbuphine, nalmefene, naloxone and naltrexone and their respective salts, but including the following:
(A) |
Raw opium |
9600 |
(B) |
Opium extracts |
9610 |
(C) |
Opium fluid |
9620 |
(D) |
Powdered opium |
9639 |
(E) |
Granulated opium |
9640 |
(F) |
Tincture of opium |
9630 |
(G) |
Codeine |
9050 |
(H) |
Ethylmorphine |
9190 |
(I) |
Etorphine hydrochloride |
9059 |
(J) |
Hydrocodone |
9193 |
(K) |
Hydromorphone |
9150 |
(L) |
Metopon |
9260 |
(M) |
Morphine |
9300 |
(N) |
Oxycodone |
9143 |
(O) |
Oxymorphone |
9652 |
(P) |
Thebaine |
9333 |
(Q) |
Dihydroetorphine |
9334 |
(R) |
Oripavine |
9330 |
(2) Any salt, compound, isomer, derivative or preparation thereof which is chemically equivalent or identical with any of the substances referred to in paragraph (1), but not including the isoquinoline alkaloids of opium.
(3) Opium poppy and poppy straw.
(4) Coca leaves (9040) and any salt, compound, derivative or preparation of coca leaves, but not including decocainized coca leaves or extractions which do not contain cocaine (9041) or ecgonine (9180).
(5) Cocaine, its salts, isomers and salts of isomers (9041).
(6) Ecgonine, its salts, isomers and salts of isomers (9180).
(7) Concentrate of poppy straw (the crude extract of poppy straw in either liquid, solid or powder form which contains the phenanthrene alkaloids of the opium poppy) (9670).
(c) Any of the following opiates, including their isomers, esters, ethers, salts and salts of isomers, esters and ethers, whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation dextrorphan and levopropoxyphene excepted:
(1) |
Alfentanil |
9737 |
(2) |
Alphaprodine |
9010 |
(3) |
Anileridine |
9020 |
(4) |
Bezitramide |
9800 |
(5) |
Bulk dextropropoxyphene (nondosage forms) |
9273 |
(6) |
Carfentanil |
9743 |
(7) |
Dihydrocodeine |
9120 |
(8) |
Diphenoxylate |
9170 |
(9) |
Fentanyl |
9801 |
(10) |
Isomethadone |
9226 |
(11) |
Levomethorphan |
9210 |
(12) |
Levorphanol |
9220 |
(13) |
Metazocine |
9240 |
(14) |
Methadone |
9250 |
(15) |
Methadone-intermediate, 4-cyano-2-dimethyl amino-4,4-diphenyl butane |
9254 |
(16) |
Moramide-intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid |
9802 |
(17) |
Pethidine (meperidine) |
9230 |
(18) |
Pethidine-intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine |
9232 |
(19) |
Pethidine-intermediate-B, ethyl-4-phenyl-piperidine-4-carboxylate |
9233 |
(20) |
Pethidine-intermediate-C, 1-methyl-4-phenyl-piperidine-4-carboxylic acid |
9234 |
(21) |
Phenazocine |
9715 |
(22) |
Piminodine |
9730 |
(23) |
Racemethorphan |
9732 |
(24) |
Racemorphan |
9733 |
(25) |
Sufentanil |
9740 |
(26) |
Levo-alphacetyl methadol
|
9648 |
|
||
(27) |
Remifentanil |
9739 |
(28) |
Tapentadol |
9780 |
(29) |
Thiafentanil |
9729 |
(d) Any material, compound, mixture, or preparation which contains any quantity of the following substances having a potential for abuse associated with a stimulant effect on the central nervous system:
(1) |
Amphetamine, its salts, optical isomers and salts of its optical isomers |
1100 |
(2) |
Phenmetrazine and its salts |
1631 |
(3) |
Methamphetamine, including its salts, isomers and salts of isomers |
1105 |
(4) |
Methylphenidate |
1724 |
(5) |
Lisdexamfetamine, its salts, isomers, and salts of its isomers |
1205 |
(e) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers and salts of isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:
(1) |
Amobarbital |
2125 |
(2) |
Glutethimide |
2550 |
(3) |
Secobarbital |
2315 |
(4) |
Pentobarbital |
2270 |
(5) |
Phencyclidine |
7471 |
(f) Any material, compound, mixture, or preparation which contains any quantity of the following substances:
(1) |
Immediate precursor to amphetamine and methamphetamine: |
|
|
(A) Phenylacetone Some trade or other names: phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl ketone. |
8501 |
|
||
(2) |
Immediate precursors to phencyclidine (PCP): |
|
|
(A) 1-phenylcyclohexylamine |
7460 |
|
(B) 1-piperidinocyclohexanecarbonitrile (PCC) |
8603 |
(3) |
Immediate precursor to fentanyl: |
|
|
(A) 4-anilino-N-phenethyl-4-piperidine (ANPP) |
8333 |
(g) Any material, compound, mixture or preparation which contains any quantity of the following hallucinogenic substance, its salts, isomers and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:
(1) |
Dronabinol [(-)-delta-9-trans tetrahydrocannabinol] in an oral solution in a drug product approved for marketing by the United States food and drug administration |
7365 |
(2) |
Nabilone
|
7379 |
|
(h) Any material, compound, mixture or preparation containing any of the following narcotic drugs or any salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:
(1) |
Not more than 300 milligrams of dihydrocodeinone (hydrocodone) or any of its salts per 100 milliliters or not more than 15 milligrams per dosage unit with a fourfold or greater quantity of an isoquinoline alkaloid of opium |
9805 |
(2) |
Not more than 300 milligrams of dihydrocodeinone (hydrocodone) or any of its salts per 100 milliliters or not more than 15 milligrams per dosage unit with one or more active, nonnarcotic ingredients in recognized therapeutic amounts |
9806 |
History: L. 1972, ch. 234, § 7; L. 1974, ch. 258, § 3; L. 1978, ch. 257, § 1; L. 1980, ch. 195, § 2; L. 1982, ch. 269, § 3; L. 1985, ch. 220, § 2; L. 1986, ch. 241, § 2; L. 1987, ch. 244, § 2; L. 1989, ch. 200, § 2; L. 1991, ch. 199, § 2; L. 1992, ch. 174, § 2; L. 1994, ch. 54, § 2; L. 2000, ch. 108, § 2; L. 2011, ch. 83, § 4; L. 2015, ch. 27, § 2; L. 2017, ch. 57, § 5; L. 2018, ch. 101, § 2; May 24.
Revisor’s Note:
Section was also amended by L. 2011, ch. 10, § 2, but that version was repealed by L. 2011, ch. 83, § 9.
NEW
2021 New, Amended and Repealed Statutes2021 SPECIAL SESSION
Information for Special Session 2021
LEGISLATIVE COORDINATING COUNCIL
6/16/2022
Meeting Notice
Agenda2/23/2022 Meeting Notice Agenda 1/7/2022 Meeting Notice Agenda LCC Policies KANSAS COMMISSION ON INTERSTATE
6/29/2022
Meeting Notice
Agenda
COOPERATION REVISOR OF STATUTES
2021 Interim Assignments2022 Valid Section Numbers Chapter 72 Statute Transfer List Kansas School Equity & Enhancement Act Gannon v. State General Information, Legal Analysis & Research 2021 Amended & Repealed Statutes 2020 Amended & repealed Statutes 2019 Amended & Repealed Statutes USEFUL LINKS
Session Laws
OTHER LEGISLATIVE SITES
Kansas LegislatureAdministrative Services Division of Post Audit Research Department |